A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban with Placebo for Reducing the Risk of Death, MI or Stroke in Subjects with HF and CAD

  • Brown, Martin (Primary Chief Investigator)
  • Butala, Radhika (Research Coordinator)

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/09/15 → 30/06/17